Stock MRK MERCK & CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 21:00:02 09/05/2024 BST 		5-day change 1st Jan Change
130.2 USD +0.52% Intraday chart for Merck & Co., Inc. +1.54% +19.46%
04:44pm Merck Says Health Canada Approve Keytruda Combination in Biliary Tract Carcinoma MT
03:21pm Sector Update: Health Care Stocks Steady Pre-Bell Thursday MT

ETFs positioned on Merck & Co., Inc.

Name Weight AuM 1st Jan change Investor Rating
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF - Distributing - EUR
0.33% 0 M€ +7.83% -
FIDELITY U.S. LOW VOLATILITY CURRENCY NEUTRAL INDEX ETF - CAD ETF Fidelity U.S. Low Volatility Currency Neutral Index ETF - CAD
0.33% 0 M€ -.--% -
VANECK MULTI-ASSET BALANCED ALLOCATION UCITS ETF - EUR ETF VanEck Multi-Asset Balanced Allocation UCITS ETF - EUR
0.32% 0 M€ +2.74% -
FIDELITY U.S. HIGH DIVIDEND CURRENCY NEUTRAL INDEX ETF - CAD ETF Fidelity U.S. High Dividend Currency Neutral Index ETF - CAD
0.32% 0 M€ +6.90% -
FIDELITY U.S. HIGH QUALITY CURRENCY NEUTRAL INDEX ETF - CAD ETF Fidelity U.S. High Quality Currency Neutral Index ETF - CAD
0.32% 0 M€ +6.12% -
CABANA TARGET LEADING SECTOR MODERATE ETF - USD ETF Cabana Target Leading Sector Moderate ETF - USD
0.30% 0 M€ -0.84% -
JPMORGAN ACTIVEBUILDERS U.S. LARGE CAP EQUITY ETF - USD ETF JPMorgan ActiveBuilders U.S. Large Cap Equity ETF - USD
0.25% 26 M€ +16.85% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Acc - EUR
0.24% 0 M€ +5.52% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Distributing - EUR
0.24% 0 M€ +5.36% -
RH TACTICAL ROTATION ETF - USD ETF RH Tactical Rotation ETF - USD
0.24% 0 M€ +11.45% -
ADAPTIVE RH HEDGED MULTI-ASSET INCOME ETF - USD ETF Adaptive RH Hedged Multi-Asset Income ETF - USD
0.23% 0 M€ +3.88% -
VANECK MULTI-ASSET CONSERVATIVE ALLOCATION UCITS ETF - EUR ETF VanEck Multi-Asset Conservative Allocation UCITS ETF - EUR
0.23% 0 M€ +0.99% -
SYNTAX STRATIFIED TOTAL MARKET II ETF - USD ETF Syntax Stratified Total Market II ETF - USD
0.21% 0 M€ +5.47% -
SYNTAX STRATIFIED U.S. TOTAL MARKET HEDGED ETF - USD ETF Syntax Stratified U.S. Total Market Hedged ETF - USD
0.21% 0 M€ +1.36% -
SYNTAX STRATIFIED U.S. TOTAL MARKET ETF - USD ETF Syntax Stratified U.S. Total Market ETF - USD
0.21% 0 M€ +5.47% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF Acc - EUR
0.19% 0 M€ +3.25% -
IQ REAL RETURN ETF - USD ETF IQ Real Return ETF - USD
0.17% 6 M€ +3.89%
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF - Distributing - EUR
0.16% 0 M€ +2.51% -
STRATEGY SHARES NASDAQ 5HANDL INDEX ETF - USD ETF Strategy Shares Nasdaq 5HANDL Index ETF - USD
0.11% 2 M€ +3.16% -
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 20% Equity UCITS ETF Acc - EUR
0.10% 0 M€ +0.45% -
2345

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
Pharmaceuticals
Calendar
15/05/2024 - Bank of America Securities Healthcare Conference
Related indices
Dow Jones Industrial , S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.6 USD
Average target price
141.6 USD
Spread / Average Target
+9.33%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 328B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 358B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 165B
PFIZER, INC. Stock Pfizer, Inc.
-2.12% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Funds and ETFs Merck & Co., Inc.